
2027年までの北米の経皮的機械的循環補助装置市場予測 - 新型コロナウイルス感染症の影響と製品別地域分析(大動脈内バルーンポンプ、VA-体外膜型人工肺(ECMO)、短期心室補助装置)。エンドユーザー (病院、外来手術センター、その他)。と国
No. of Pages: 102 | Report Code: TIPRE00018222 | Category: Life Sciences
No. of Pages: 102 | Report Code: TIPRE00018222 | Category: Life Sciences
経皮的機械循環サポート装置は、代償不全に苦しむ患者の血行力学的不安定性の下降スパイラルを遅らせる効果的かつ迅速なアプローチを提供します。心不全や心原性ショックは、これらの心臓病から回復するためのより決定的な戦略が患者の間で認識されるまで続きます。経皮的機械的循環補助装置の主な役割には、自然心拍出量の改善、心室容積と充満圧の減少、冠動脈灌流の増強、重要臓器灌流の維持などが含まれます。
北米の経皮的機械循環サポート装置市場は、2019 年の 6 億 4,523 万米ドルから 2027 年までに 17 億 4,925 万米ドルに達すると予想されています。 2019 年から 2027 年にかけての CAGR は 13.6% でした。高齢者人口の増加、心血管疾患の有病率の増加、心臓ドナーの不足は、北米の経皮的機械循環補助装置市場の成長を促進すると予想される主な要因です。ただし、市場は、予測期間中に、これらの機器やそれに関連する手順の高額なコスト、製品のリコール、医療機器業界に対する新型コロナウイルス感染症のパンデミックの影響による影響を受ける可能性があります。
製品に関しては、大動脈内バルーンポンプ (IABP) セグメントが北米の経皮ポンプ市場で最大のシェアを占めました。 2019 年の機械的循環補助装置市場。エンドユーザーに関しては、2019 年の北米の経皮的機械的循環補助装置市場で病院部門が最大のシェアを占めました。
北米の経皮的機械循環補助装置市場レポートに関連するいくつかの主要な一次および二次情報源は、世界保健機関 (WHO)、心臓病、および脳卒中統計、国立衛生研究所 (NIH)、疾病管理予防センター (CDC)、米国心不全協会、カナダ心臓脳卒中財団、カナダ心臓脳卒中財団など。 p>
Strategic insights for North America Percutaneous Mechanical Circulatory Support Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 645.23 Million |
Market Size by 2027 | US$ 1,749.25 Million |
Global CAGR (2019 - 2027) | 13.6% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By 製品
|
Regions and Countries Covered | 北米
|
Market leaders and key company profiles |
The regional scope of North America Percutaneous Mechanical Circulatory Support Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Percutaneous Mechanical Circulatory Support Devices Market is valued at US$ 645.23 Million in 2019, it is projected to reach US$ 1,749.25 Million by 2027.
As per our report North America Percutaneous Mechanical Circulatory Support Devices Market, the market size is valued at US$ 645.23 Million in 2019, projecting it to reach US$ 1,749.25 Million by 2027. This translates to a CAGR of approximately 13.6% during the forecast period.
The North America Percutaneous Mechanical Circulatory Support Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Percutaneous Mechanical Circulatory Support Devices Market report:
The North America Percutaneous Mechanical Circulatory Support Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Percutaneous Mechanical Circulatory Support Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Percutaneous Mechanical Circulatory Support Devices Market value chain can benefit from the information contained in a comprehensive market report.